Volume 4 Supplement 2

Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research

Meeting abstracts

Publication of this supplement was made possible with support from the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health.

11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research. Go to conference site.

Bethesda, MD, USA6-7 October 2008

Concatenated PDF 4S2

Page 1 of 2

Content type: Poster presentation

A retrospective analysis of HIV-associated Kaposi's sarcoma in patients with non-detectable HIV viral loads and CD4+ counts greater than 300 cells/μL

Authors: D Mani and D Aboulafia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P1

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Development and application of a real time PCR assay for detection and quantification of merkel cell virus (MCV) in archived formalin fixed paraffin embedded tissue samples of merkel cell carcinoma and other cancers

Authors: R Modali, J Goedert, E Engels, LW Ayers and K Bhatia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O1

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

AIDS-associated plasmablastic lymphoma presenting as a poorly differentiated esophageal tumor: a diagnostic dilemma

Authors: D Mani, D Guinee Jr and D Aboulafia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P2

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study

Authors: J Bohlius

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O2

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Four year survival in untreated AIDS related-Kaposi sarcoma (AIDS-KS) in Jos, Nigeria

Authors: P Agaba, E Anya, Z Hassan, L Apena, O Agbaji, M Mua'Zu, B Badung and J Idoko

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P3

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

Authors: M Bruyand, R Thiebaut, F Dabis, S Lawson-Ayayi, P Joly, AJ Sasco, P Mercie, JL Pellegrin, S Geffard, D Neau, P Morlat, G Chene and F Bonnet

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O3

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Malignancies in HIV infected children at a tertiary cancer hospital in India

Authors: A Alahari Dhir, S Sawant, G Bharia and S Banavali

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P4

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

A population-based study of how children are exposed to saliva in Africa: implications for KSHV transmission

Authors: LM Butler, S Mzolo, A Mosam and JN Martin

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O4

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Suppression of galectin-3 in KSHV infected DMVEC cells and Kaposi's sarcoma: implications for tumorigenesis

Authors: DJ Alcendor, WQ Zhu, P Desai and GS Hayward

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P5

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy

Authors: HQ Nguyen, F Okuku, F Ssewankambo, AS Magaret, C Johnston, A Wald, A Kambugu, L Corey, J Orem and C Casper

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O5

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting

Authors: LW Ayers, M Ogwang, W Zhou, SM Mbulaiteye and K Bhatia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P6

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

Authors: GM Clifford, M Rickenbach and S Franceschi

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O6

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Evaluation of Epstein-Barr virus (EBV) and human herpes virus-8 (HHV-8) in HIV-associated persistent generalized lymphadenopathy (PGL)

Authors: LW Ayers, G Dominguez and K Bhatia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P7

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers

Authors: A Bhatt, P Bhende and B Damania

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O7

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Therapeutic options in AIDS related Kaposi's sarcoma: a 5-year Nigerian review

Authors: AA Babadoko, MS Shehu, SM Aminu and AM Suleiman

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P8

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

High resolution profiling of DNA copy number and gene expression changes in AIDS-related lymphoma

Authors: KE Deffenbacher, Z Liu, J Iqbal, H Geng, K Fu and WC Chan

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O8

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Dendritic cell-mediated infection of primary B cells with KSHV

Authors: R Bagni, E Barsov, B Ortiz-Conde, D Dittmer, V Kewalramani, D Ott, C Sadowski, P Tuma, F Ruscetti and D Whitby

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P9

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab

Authors: K Dunleavy, RF Little, AS Wayne, N Grant, S Pittaluga, ES Jaffe, S Steinberg, R Yarchoan, J Carrasquillo, J Janik and WH Wilson

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O9

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Survival and prognosis of HIV-associated non-Hodgkin-lymophma in the era of combined anti-retroviral therapy, a European multi-cohort study

Authors: J Bohlius

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P10

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Epidemiology of non-keratinocytic skin cancers among persons with AIDS in the United States

Authors: E Lanoy, GM Dores, MM Madeleine, JR Toro, JF Fraumeni and EA Engels

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O10

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women

Authors: ML Tornesello, L Buonaguro, S Izzo, G Lopez, X Vega, CF Maldonado Reyes and FM Buonaguro

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P11

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

HIV induces the expression of activation-induced cytidine deaminase (AICDA) in B cells through a direct interaction between virion-associated CD40L and CD40

Authors: M Epeldegui, S Kitchen, J De La Cruz, J Zack and O Martinez-Maza

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O11

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Regulatory T cells are present in Kaposi's sarcoma and increasingly frequent in advanced disease

Authors: D Camarillo, K Leslie, P Unemori, A Koba Yashi, K McCune-Smith and T Maurer

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P12

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses

Authors: P Gasperini and G Tosato

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O12

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma

Authors: P Lu, C Yang, I Guasparri, W Harrington, YL Wang and E Cesarman

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P13

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

An invasion mechanism for human papillomavirus related cancers: HPV 16 E6 degrades PTPN13 allowing enhanced map kinase signaling

Authors: AC Hoover, GL Strand, PN Nowicki, ME Anderson, AJ Klingelhutz, AD Bossler and JH Lee

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O13

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS malignancies consortium clinical trials 010 and 034

Authors: A Chadburn, A Chiu, Y Lee, X Chen, E Hyjek, A Banhmam, A Noy, A Kaplan, J Sparano, K Bhatia and E Cesarman

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P14

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)

Authors: A Krishnan, J Zaia, J Alvarnas, N Kogut, J Cai, A Nademanee, J Palmer, N Tsai and SJ Forman

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O14

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Marijuana use and cervical HPV/neoplasia

Authors: G D'Souza, R Burk, Y Zhong, H Minkoff, LS Massad, K Anastos, A Levine, M Moxley, X Xue, J Palefsky and HD Strickler

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P15

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study

Authors: E Lanoy, JP Spano, F Bonnet, F Boué, C Katlama and D Costagliola

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O15

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo

Authors: AL Dufresne, D Fu and RF Ambinder

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P16

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer

Authors: PW Nowicki, WC Spanos, DW Lee, ME Anderson, AJ Hoover and JH Lee

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O16

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Kaposi sarcoma incidence in the Swiss HIV cohort study before and after highly active antiretroviral therapy

Authors: S Franceschi, L Dal Maso, M Rickenbach, J Polesel and GM Clifford

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P17

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation

Authors: JN Martin, M Laker, A Kambugu, D Janka, J Orem, A Mwaka, T Maurer and EK Mbidde

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O17

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Kaposi's sarcoma-associated herpes virus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin

Authors: LW Qian, W Greene, FC Ye and SJ Gao

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P18

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Preliminary findings on cancer incidence in HIV-infected persons from six countries in Central and South America and the Caribbean

Authors: DR Masys, F Fang, I Ye, V Fink, E Gotuzzo, D Padgett, JW Pape, C Cortes, M Bacon and M Schechter

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O18

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

The role of the TRAF2/3 binding site in LMP1 and CD40 signaling

Authors: JP Graham and GA Bishop

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P19

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Profiling of cellular and viral microRNAs in Kaposi sarcoma and viral-associated lymphoma

Authors: DP Dittmer, AJ O'Hara, L Wang, BJ Dezube, W Harrington Jr and B Damania

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O19

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

KSHV seroprevalence, and blood and saliva viral loads in the HIV-infected population of south Texas

Authors: M Guadalupe, Y Flahive, S Westbrook, S Redding, D Bullock, V Sankar, B Agan, S Barbieri, CK Yeh, H Dang and SJ Gao

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P20

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)

Authors: R Yarchoan, D O'Mahony, K Aleman, KM Wyvill, D Whitby, W Bernstein, S Pittaluga, ES Jaffe, G Tosato, DA Davis, SM Steinberg and RF Little

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O20

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States

Authors: M Guech-Ongey, EA Engels, JJ Goedert, RJ Biggar and SM Mbulaiteye

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P21

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Implementation of a "see and treat" cervical cancer prevention program linked to HIV care in Zambia

Authors: KS Pfaendler, MH Mwanahamuntu, VV Sahasrabuddhe, JSA Stringer, MI Hicks and GP Parham

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O21

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Burkitt lymphoma in Brazil is characterized by geographically distinct clinico-pathological features and lack of p53 mutations

Authors: E Queiroga, G Gualco, L Weiss, D Dittmer, I Araujo, C Klumb, W Harrington Jr, E Os and C Bacchi

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P22

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Trends in cancer incidence among HIV-infected persons in California, 1996–2006

Authors: MJ Silverberg, WA Leyden, C Chao, M Horberg, D Klein, W Towner and DI Abrams

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O22

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Bortezomib-induced enzyme-targeted radiotherapy (BETR) for AIDS-related malignancies: efficacy assessment by Monte Carlo and dosimetry modeling

Authors: R Hobbs, D Fu, M Pomper, R Ambinder and G Sgouros

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P23

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Profiling viral and host microRNA expression in cells infected with KSHV and EBV

Authors: D Whitby, W Miley, R Bagni, V Marshall, S-J HanJ, J Hu, RL Skalsky, CH Kim, F Ruscetti, R Little, R Yarchoan and R Renne

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O23

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Tobacco, alcohol and use of other recreational drugs within HIV-infected treated cohorts: the IeDEA West Africa collaboration

Authors: A Jaquet, DK Ekouevi, J Bashi, M Aboubakrine, E Messou, M Maiga, D Zannou, C Guei, O Ba-Gomis, A Minga, G Allou, J Sasco and F Dabis

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P24

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Expression and function of the chemokine, CXCL13, and its receptor, CXCR5, in AIDS-associated non-Hodgkin's lymphoma

Authors: DP Widney, D Gui, JW Said, EC Breen, R Detels and O Martinez-Maza

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O24

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Poster presentation

Anal and cervical cytologic abnormalities among HIV-infected women in the era of HAART

Authors: EM Kojic, C Wang, L Boardman and S Cu-Uvin

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P25

Published on: 17 June 2009
- View Full Text
- View PDF
Content type: Oral presentation

Risk of death among Italian AIDS cases with AIDS-defining cancers in the post-HAART era

Authors: D Serraino, S Bruzzone, B Suligoi, A De Paoli, J Polesel, B Longo, S Boros, P Piselli, L Dal Maso, L Camoni and G Rezza

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O25

Published on: 17 June 2009
- View Full Text
- View PDF

Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research

Meeting abstracts

Affiliated with

Follow

Annual Journal Metrics

Infectious Agents and Cancer

Contact us